scispace - formally typeset
Y

Yuji Hinoda

Researcher at Yamaguchi University

Publications -  293
Citations -  11955

Yuji Hinoda is an academic researcher from Yamaguchi University. The author has contributed to research in topics: Cancer & Antigen. The author has an hindex of 62, co-authored 292 publications receiving 11460 citations. Previous affiliations of Yuji Hinoda include University of California, San Francisco & University of Dundee.

Papers
More filters
Journal ArticleDOI

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

TL;DR: It is shown that restoration of SFRP function in colorectal cancer cells attenuates WNT signaling even in the presence of downstream mutations, and that the epigenetic loss of SfrP function occurs early in coloresceptic cancer progression and may thus provide constitutive W NT signaling that is required to complement downstream mutations in the evolution of coloreCTal cancer.
Journal ArticleDOI

Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205.

TL;DR: It is found that MALAT1 expression was higher in human RCC tissues, where it was associated with reduced patient survival and its interactions with Ezh2 and miR-205 were investigated.
Journal ArticleDOI

Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.

TL;DR: Matrilysin showed a correlation with metastasis in a cohort of 83 colorectal cancer patients and marked metastatic potentiation in human coloreCTal cancer xenografts, indicating that it may play a critical role in the metastatic pathway of colorectoral cancers.
Journal ArticleDOI

Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases.

TL;DR: The findings suggest that serum ICAM‐1 antigen may be a useful marker to monitor tumor burden in cancer patients.
Journal ArticleDOI

Distinct methylation pattern and microsatellite instability in sporadic gastric cancer.

TL;DR: The data showed a significant correlation between hMLH1 methylation and MSI in GC, and suggested that a common mechanism of aberrant de novo methylation can be postulated in these cancers.